Amarin Corporation plc (AMRN)
USD 0.4
(0.32%)
USD 0.4
(0.32%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 306.91 Million USD | -16.55% |
| 2022 | 369.19 Million USD | -36.69% |
| 2021 | 583.18 Million USD | -5.03% |
| 2020 | 614.06 Million USD | 42.89% |
| 2019 | 429.75 Million USD | 87.49% |
| 2018 | 229.21 Million USD | 26.56% |
| 2017 | 181.1 Million USD | 39.22% |
| 2016 | 130.08 Million USD | 59.11% |
| 2015 | 81.75 Million USD | 50.84% |
| 2014 | 54.2 Million USD | 105.69% |
| 2013 | 26.35 Million USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 7.36 Million USD | 1373.0% |
| 2006 | 500 Thousand USD | 0.0% |
| 2005 | 500 Thousand USD | -50.84% |
| 2004 | 1.01 Million USD | -86.19% |
| 2003 | 7.36 Million USD | -88.76% |
| 2002 | 65.5 Million USD | 21.82% |
| 2001 | 53.77 Million USD | 206.36% |
| 2000 | 17.55 Million USD | 56.46% |
| 1999 | 11.21 Million USD | -40.96% |
| 1998 | 19 Million USD | -21.81% |
| 1997 | 24.3 Million USD | 13.02% |
| 1996 | 21.5 Million USD | -26.12% |
| 1995 | 29.1 Million USD | 55.61% |
| 1994 | 18.7 Million USD | 27.21% |
| 1993 | 14.7 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 41.85 Million USD | -37.4% |
| 2024 Q2 | 67.56 Million USD | 19.62% |
| 2024 Q1 | 56.48 Million USD | -25.05% |
| 2023 Q4 | 75.36 Million USD | 14.09% |
| 2023 Q2 | 80.16 Million USD | -6.76% |
| 2023 FY | 308.1 Million USD | -16.55% |
| 2023 Q3 | 66.05 Million USD | -17.6% |
| 2023 Q1 | 85.97 Million USD | -4.73% |
| 2022 Q1 | 94.63 Million USD | -34.51% |
| 2022 Q2 | 94.44 Million USD | -0.2% |
| 2022 Q4 | 90.24 Million USD | 0.41% |
| 2022 FY | 369.19 Million USD | -36.69% |
| 2022 Q3 | 89.87 Million USD | -4.83% |
| 2021 FY | 583.18 Million USD | -5.03% |
| 2021 Q3 | 142.03 Million USD | -8.06% |
| 2021 Q1 | 142.17 Million USD | -15.0% |
| 2021 Q2 | 154.48 Million USD | 8.66% |
| 2021 Q4 | 144.49 Million USD | 1.73% |
| 2020 Q4 | 167.25 Million USD | 6.87% |
| 2020 FY | 614.06 Million USD | 42.89% |
| 2020 Q3 | 156.49 Million USD | 15.65% |
| 2020 Q2 | 135.31 Million USD | -12.69% |
| 2020 Q1 | 154.99 Million USD | 8.18% |
| 2019 FY | 429.75 Million USD | 87.49% |
| 2019 Q4 | 143.27 Million USD | 27.46% |
| 2019 Q3 | 112.4 Million USD | 11.52% |
| 2019 Q2 | 100.79 Million USD | 37.55% |
| 2019 Q1 | 73.27 Million USD | -5.24% |
| 2018 Q4 | 77.33 Million USD | 39.78% |
| 2018 FY | 229.21 Million USD | 26.56% |
| 2018 Q1 | 43.91 Million USD | -18.47% |
| 2018 Q2 | 52.64 Million USD | 19.86% |
| 2018 Q3 | 55.32 Million USD | 5.09% |
| 2017 Q3 | 47.36 Million USD | 4.68% |
| 2017 Q2 | 45.24 Million USD | 30.61% |
| 2017 FY | 181.1 Million USD | 39.22% |
| 2017 Q1 | 34.63 Million USD | -10.49% |
| 2017 Q4 | 53.86 Million USD | 13.74% |
| 2016 Q4 | 38.69 Million USD | 18.21% |
| 2016 Q3 | 32.73 Million USD | -1.14% |
| 2016 Q2 | 33.11 Million USD | 29.63% |
| 2016 Q1 | 25.54 Million USD | -4.09% |
| 2016 FY | 130.08 Million USD | 59.11% |
| 2015 Q2 | 17.7 Million USD | 11.13% |
| 2015 Q4 | 26.63 Million USD | 23.97% |
| 2015 Q3 | 21.48 Million USD | 21.32% |
| 2015 Q1 | 15.93 Million USD | -3.32% |
| 2015 FY | 81.75 Million USD | 50.84% |
| 2014 FY | 54.2 Million USD | 105.69% |
| 2014 Q1 | 10.96 Million USD | 8.52% |
| 2014 Q3 | 14.14 Million USD | 12.24% |
| 2014 Q2 | 12.6 Million USD | 14.94% |
| 2014 Q4 | 16.48 Million USD | 16.47% |
| 2013 Q1 | 2.34 Million USD | 0.0% |
| 2013 FY | 26.35 Million USD | 0.0% |
| 2013 Q3 | 8.4 Million USD | 52.78% |
| 2013 Q4 | 10.1 Million USD | 20.27% |
| 2013 Q2 | 5.5 Million USD | 134.94% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | -100.0% |
| 2008 FY | - USD | -100.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | 7.36 Million USD | 0.0% |
| 2007 FY | 7.36 Million USD | 1373.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2006 Q3 | 100 Thousand USD | 0.0% |
| 2006 Q1 | - USD | -100.0% |
| 2006 Q4 | 400 Thousand USD | 300.0% |
| 2006 FY | 500 Thousand USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 100.0% |
| 2005 FY | 500 Thousand USD | -50.84% |
| 2005 Q3 | 250 Thousand USD | 0.0% |
| 2005 Q4 | 250 Thousand USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | -100.0% |
| 2004 Q4 | -1.55 Million USD | 0.0% |
| 2004 Q1 | 1.04 Million USD | 102.19% |
| 2004 Q2 | 509 Thousand USD | -51.34% |
| 2004 FY | 1.01 Million USD | -86.19% |
| 2003 Q3 | 15.17 Million USD | 484.78% |
| 2003 Q1 | 14.87 Million USD | 6.74% |
| 2003 Q2 | 2.59 Million USD | -82.56% |
| 2003 FY | 7.36 Million USD | -88.76% |
| 2003 Q4 | -47.67 Million USD | -414.19% |
| 2002 Q4 | 13.93 Million USD | -5.96% |
| 2002 Q3 | 14.82 Million USD | -22.54% |
| 2002 Q2 | 19.13 Million USD | 8.69% |
| 2002 Q1 | 17.6 Million USD | 15.28% |
| 2002 FY | 65.5 Million USD | 21.82% |
| 2001 Q3 | 15.88 Million USD | -5.46% |
| 2001 Q4 | 15.27 Million USD | -3.83% |
| 2001 FY | 53.77 Million USD | 206.36% |
| 2001 Q1 | 5.81 Million USD | 29.52% |
| 2001 Q2 | 16.8 Million USD | 188.76% |
| 2000 Q1 | 4.32 Million USD | 0.0% |
| 2000 Q3 | 5.35 Million USD | 50.0% |
| 2000 Q2 | 3.56 Million USD | -17.48% |
| 2000 Q4 | 4.49 Million USD | -16.07% |
| 2000 FY | 17.55 Million USD | 56.46% |
| 1999 Q1 | 5.1 Million USD | 13.33% |
| 1999 Q3 | 3.3 Million USD | -44.07% |
| 1999 FY | 11.21 Million USD | -40.96% |
| 1999 Q2 | 5.9 Million USD | 15.69% |
| 1998 Q3 | 5.2 Million USD | 13.04% |
| 1998 FY | 19 Million USD | -21.81% |
| 1998 Q4 | 4.5 Million USD | -13.46% |
| 1998 Q2 | 4.6 Million USD | 0.0% |
| 1998 Q1 | 4.6 Million USD | -4.17% |
| 1997 Q2 | 6.1 Million USD | 17.31% |
| 1997 FY | 24.3 Million USD | 13.02% |
| 1997 Q1 | 5.2 Million USD | -1.89% |
| 1997 Q4 | 4.8 Million USD | -38.46% |
| 1997 Q3 | 7.8 Million USD | 27.87% |
| 1996 Q3 | 9.1 Million USD | 116.67% |
| 1996 FY | 21.5 Million USD | -26.12% |
| 1996 Q1 | 4.1 Million USD | 0.0% |
| 1996 Q4 | 5.3 Million USD | -41.76% |
| 1996 Q2 | 4.2 Million USD | 2.44% |
| 1995 Q2 | 7.3 Million USD | 0.0% |
| 1995 Q3 | 7.2 Million USD | -1.37% |
| 1995 Q1 | 7.3 Million USD | 0.0% |
| 1995 FY | 29.1 Million USD | 55.61% |
| 1995 Q4 | 4.1 Million USD | -43.06% |
| 1994 Q3 | 13.1 Million USD | 523.81% |
| 1994 Q4 | 7.3 Million USD | -44.27% |
| 1994 FY | 18.7 Million USD | 27.21% |
| 1994 Q1 | 3.1 Million USD | 47.62% |
| 1994 Q2 | 2.1 Million USD | -32.26% |
| 1993 Q2 | 600 Thousand USD | 0.0% |
| 1993 FY | 14.7 Million USD | 0.0% |
| 1993 Q4 | 2.1 Million USD | -83.33% |
| 1993 Q3 | 12.6 Million USD | 2000.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -707.13% |
| Alkermes plc | 1.66 Billion USD | 81.549% |
| Agenus Inc. | 156.31 Million USD | -96.343% |
| Aptorum Group Limited | 431.37 Thousand USD | -71046.651% |
| Ardelyx, Inc. | 124.45 Million USD | -146.602% |
| Dyadic International, Inc. | 2.89 Million USD | -10487.497% |
| Eton Pharmaceuticals, Inc. | 31.64 Million USD | -869.948% |
| Lantern Pharma Inc. | - USD | -Infinity% |
| Inhibikase Therapeutics, Inc. | 260.5 Thousand USD | -117716.123% |
| Novavax, Inc. | 983.7 Million USD | 68.801% |
| Janux Therapeutics, Inc. | 8.08 Million USD | -3696.994% |
| Pyxis Oncology, Inc. | - USD | -Infinity% |
| TransCode Therapeutics, Inc. | - USD | -Infinity% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1511.166% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Madrigal Pharmaceuticals, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 9.93 Million USD | -2988.879% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -38168.204% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 163.91 Million USD | -87.239% |
| Clearside Biomedical, Inc. | 8.22 Million USD | -3630.987% |
| C4 Therapeutics, Inc. | 20.75 Million USD | -1378.662% |
| Alnylam Pharmaceuticals, Inc. | 1.82 Billion USD | 83.213% |
| AlloVir, Inc. | - USD | -Infinity% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -27.489% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -72284.67% |
| Bicycle Therapeutics plc | 26.97 Million USD | -1037.719% |
| BioXcel Therapeutics, Inc. | 1.38 Million USD | -22139.928% |
| ChromaDex Corporation | 83.57 Million USD | -267.25% |
| Chimerix, Inc. | 324 Thousand USD | -94625.617% |
| Corbus Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | 34.47 Million USD | -790.191% |
| CRISPR Therapeutics AG | 371.2 Million USD | 17.321% |
| Precision BioSciences, Inc. | 48.72 Million USD | -529.858% |
| Fate Therapeutics, Inc. | 63.53 Million USD | -383.073% |
| Fortress Biotech, Inc. | 84.51 Million USD | -263.152% |
| Fortress Biotech, Inc. | 84.51 Million USD | -263.152% |
| HOOKIPA Pharma Inc. | 20.12 Million USD | -1424.721% |
| ImmuCell Corporation | 17.47 Million USD | -1656.621% |
| IDEAYA Biosciences, Inc. | 23.38 Million USD | -1212.427% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Incyte Corporation | 3.69 Billion USD | 91.695% |
| Innoviva, Inc. | 310.46 Million USD | 1.144% |
| IO Biotech, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 9.76 Million USD | -3044.258% |
| Keros Therapeutics, Inc. | 151 Thousand USD | -203152.318% |
| Ligand Pharmaceuticals Incorporated | 131.31 Million USD | -133.723% |
| ContextLogic Inc. | 287 Million USD | -6.938% |
| MiMedx Group, Inc. | 321.47 Million USD | 4.531% |
| MEI Pharma, Inc. | 65.29 Million USD | -370.023% |
| NextCure, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 58.46 Thousand USD | -524848.26% |
| Oncternal Therapeutics, Inc. | 785 Thousand USD | -38996.943% |
| Opthea Limited | 261.85 Thousand USD | -117104.679% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Vaxcyte, Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | - USD | -Infinity% |
| Precigen, Inc. | 6.22 Million USD | -4830.297% |
| Pharming Group N.V. | 245.31 Million USD | -25.108% |
| Phathom Pharmaceuticals, Inc. | 682 Thousand USD | -44901.613% |
| Pieris Pharmaceuticals, Inc. | 42.81 Million USD | -616.914% |
| PureTech Health plc | 3.33 Million USD | -9116.547% |
| Rigel Pharmaceuticals, Inc. | 116.88 Million USD | -162.582% |
| Avidity Biosciences, Inc. | 9.56 Million USD | -3110.366% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 176.23 Million USD | -74.152% |
| Sol-Gel Technologies Ltd. | 1.55 Million USD | -19649.743% |
| Acelyrin, Inc. | - USD | -Infinity% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Summit Therapeutics Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | - USD | -Infinity% |
| Senti Biosciences, Inc. | 2.56 Million USD | -11884.03% |
| Stoke Therapeutics, Inc. | 8.78 Million USD | -3395.569% |
| Elevation Oncology, Inc. | - USD | -Infinity% |
| Alaunos Therapeutics, Inc. | 5000.00 USD | -6138120.0% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 129.01 Million USD | -137.892% |
| VistaGen Therapeutics, Inc. | 1.06 Million USD | -28745.019% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Wave Life Sciences Ltd. | 113.3 Million USD | -170.872% |
| Seer, Inc. | 15.18 Million USD | -1921.545% |
| Verrica Pharmaceuticals Inc. | 5.12 Million USD | -5889.676% |
| Aadi Bioscience, Inc. | 24.35 Million USD | -1160.208% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 10 Thousand USD | -3069010.0% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 1.8 Million USD | -16950.611% |
| Akebia Therapeutics, Inc. | 194.62 Million USD | -57.695% |
| Catalyst Pharmaceuticals, Inc. | 398.2 Million USD | 22.926% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 2.76 Million USD | -11019.964% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Sorrento Therapeutics, Inc. | 62.83 Million USD | -388.408% |
| TRACON Pharmaceuticals, Inc. | 12.04 Million USD | -2448.037% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptose Biosciences Inc. | - USD | -Infinity% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 839.35 Thousand USD | -36464.926% |
| Century Therapeutics, Inc. | 2.23 Million USD | -13632.036% |
| Kura Oncology, Inc. | - USD | -Infinity% |
| TScan Therapeutics, Inc. | 21.04 Million USD | -1358.079% |
| Intensity Therapeutics, Inc. | - USD | -Infinity% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 101.21 Million USD | -203.23% |
| Autolus Therapeutics plc | 1.69 Million USD | -17974.853% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 46.01 Million USD | -566.937% |
| Eterna Therapeutics Inc. | 68 Thousand USD | -451239.706% |
| Adaptive Biotechnologies Corporation | 170.27 Million USD | -80.243% |
| GRI Bio, Inc. | 21.76 Million USD | -1309.983% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -11983.177% |
| Tenaya Therapeutics, Inc. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 2.13 Million USD | -14308.967% |
| INmune Bio, Inc. | 155 Thousand USD | -197907.097% |
| Heron Therapeutics, Inc. | 127.04 Million USD | -141.579% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -13607.558% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | - USD | -Infinity% |
| Milestone Pharmaceuticals Inc. | 1 Million USD | -30591.1% |
| X4 Pharmaceuticals, Inc. | - USD | -Infinity% |
| Atara Biotherapeutics, Inc. | 8.57 Million USD | -3479.972% |
| Coherus BioSciences, Inc. | 257.24 Million USD | -19.307% |
| Verastem, Inc. | - USD | -Infinity% |
| Abeona Therapeutics Inc. | 3.5 Million USD | -8668.886% |
| Pliant Therapeutics, Inc. | 1.58 Million USD | -19324.747% |
| Tonix Pharmaceuticals Holding Corp. | 7.76 Million USD | -3850.965% |
| Histogen Inc. | 3.76 Million USD | -8043.035% |
| Aprea Therapeutics, Inc. | 583.23 Thousand USD | -52522.546% |
| Surrozen, Inc. | - USD | -Infinity% |
| Organovo Holdings, Inc. | 109 Thousand USD | -281469.725% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 391.69 Thousand USD | -78254.587% |
| Panbela Therapeutics, Inc. | - USD | -Infinity% |
| CASI Pharmaceuticals, Inc. | 33.87 Million USD | -805.903% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.85 Million USD | -4378.491% |
| Hepion Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arcturus Therapeutics Holdings Inc. | 157.74 Million USD | -94.558% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -210401.372% |
| Apollomics, Inc. | 821 Thousand USD | -37282.582% |
| Mesoblast Limited | 5.9 Million USD | -5100.119% |
| Turnstone Biologics Corp. | 19.3 Million USD | -1489.718% |
| Kymera Therapeutics, Inc. | 78.59 Million USD | -290.512% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | - USD | -Infinity% |
| Aurinia Pharmaceuticals Inc. | 175.51 Million USD | -74.865% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.83 Billion USD | 83.231% |
| Better Therapeutics, Inc. | - USD | -Infinity% |
| Nurix Therapeutics, Inc. | 76.98 Million USD | -298.653% |
| Apellis Pharmaceuticals, Inc. | 396.59 Million USD | 22.613% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 1.33 Million USD | -22958.678% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 139.91 Million USD | -119.362% |
| Insmed Incorporated | 305.2 Million USD | -0.558% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 18.68 Million USD | -1542.465% |
| OmniAb, Inc. | 34.16 Million USD | -798.346% |
| Alector, Inc. | 97.06 Million USD | -216.201% |
| Seres Therapeutics, Inc. | 126.32 Million USD | -142.953% |
| Checkpoint Therapeutics, Inc. | 103 Thousand USD | -297871.845% |
| Zai Lab Limited | 266.71 Million USD | -15.069% |
| Revance Therapeutics, Inc. | 234.04 Million USD | -31.136% |
| Aura Biosciences, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -235985.385% |
| Immunic, Inc. | - USD | -Infinity% |
| Tarsus Pharmaceuticals, Inc. | 17.44 Million USD | -1659.105% |
| Veracyte, Inc. | 361.05 Million USD | 14.995% |
| InMed Pharmaceuticals Inc. | 4.59 Million USD | -6575.272% |
| FibroGen, Inc. | 147.75 Million USD | -107.72% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 147.8 Thousand USD | -207545.885% |
| Jazz Pharmaceuticals plc | 3.83 Billion USD | 91.995% |
| Cyclacel Pharmaceuticals, Inc. | 420 Thousand USD | -72974.048% |
| Amylyx Pharmaceuticals, Inc. | 380.78 Million USD | 19.401% |
| TG Therapeutics, Inc. | 233.66 Million USD | -31.348% |
| Galecto, Inc. | - USD | -Infinity% |
| Calithera Biosciences, Inc. | - USD | -Infinity% |
| Fortrea Holdings Inc. | 3.1 Billion USD | 90.128% |
| KalVista Pharmaceuticals, Inc. | - USD | -Infinity% |
| Aptevo Therapeutics Inc. | - USD | -Infinity% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | 1.55 Million USD | -19599.037% |
| Foghorn Therapeutics Inc. | 34.15 Million USD | -798.583% |
| Y-mAbs Therapeutics, Inc. | 84.81 Million USD | -261.842% |
| Theravance Biopharma, Inc. | 57.42 Million USD | -434.465% |
| Ultragenyx Pharmaceutical Inc. | 434.24 Million USD | 29.324% |
| Metagenomi, Inc. Common Stock | 44.75 Million USD | -585.743% |
| Vaxxinity, Inc. | - USD | -Infinity% |
| BioCryst Pharmaceuticals, Inc. | 331.41 Million USD | 7.393% |
| Gain Therapeutics, Inc. | 55.18 Thousand USD | -556099.71% |
| Cartesian Therapeutics, Inc. | 26 Million USD | -1080.245% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | 9000.00 USD | -3410022.222% |
| Marker Therapeutics, Inc. | 3.31 Million USD | -9169.063% |
| Regeneron Pharmaceuticals, Inc. | 13.11 Billion USD | 97.66% |
| Chemomab Therapeutics Ltd. | - USD | -Infinity% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | - USD | -Infinity% |
| Ainos, Inc. | 122.11 Thousand USD | -251235.659% |
| Pluri Inc. | 326 Thousand USD | -94044.479% |
| Prothena Corporation plc | 91.37 Million USD | -235.899% |
| Adaptimmune Therapeutics plc | 60.28 Million USD | -409.134% |
| Celularity Inc. | 22.77 Million USD | -1247.815% |
| Rallybio Corporation | - USD | -Infinity% |
| Cue Biopharma, Inc. | 5.49 Million USD | -5490.364% |
| MeiraGTx Holdings plc | 14.01 Million USD | -2089.563% |
| Omeros Corporation | - USD | -Infinity% |
| Humacyte, Inc. | - USD | -Infinity% |
| Immunocore Holdings plc | 249.42 Million USD | -23.046% |
| Cocrystal Pharma, Inc. | - USD | -Infinity% |
| Cidara Therapeutics, Inc. | 63.9 Million USD | -380.261% |
| Blueprint Medicines Corporation | 249.38 Million USD | -23.07% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 30.98 Million USD | -890.387% |
| Scholar Rock Holding Corporation | - USD | -Infinity% |
| Sana Biotechnology, Inc. | - USD | -Infinity% |
| Pulmatrix, Inc. | 7.29 Million USD | -4105.412% |
| Elicio Therapeutics, Inc. | - USD | -Infinity% |
| Vigil Neuroscience, Inc. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 36.27 Million USD | -746.068% |
| Adlai Nortye Ltd. American Depositary Shares | 4.99 Million USD | -6043.561% |
| Cytokinetics, Incorporated | 7.53 Million USD | -3975.843% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -14617.736% |
| Protara Therapeutics, Inc. | - USD | -Infinity% |
| Vor Biopharma Inc. | - USD | -Infinity% |
| Roivant Sciences Ltd. | 124.79 Million USD | -145.932% |
| Evogene Ltd. | 5.64 Million USD | -5341.684% |
| ProKidney Corp. | - USD | -Infinity% |
| Applied Therapeutics, Inc. | 9.99 Million USD | -2971.26% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 9.3 Million USD | -3199.054% |
| CorMedix Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 4.8 Million USD | -6293.979% |
| Tango Therapeutics, Inc. | 36.52 Million USD | -740.231% |
| Galectin Therapeutics Inc. | - USD | -Infinity% |
| Atai Life Sciences N.V. | 314 Thousand USD | -97642.357% |
| Renovaro Biosciences Inc. | - USD | -Infinity% |
| Aerovate Therapeutics, Inc. | - USD | -Infinity% |
| Zentalis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sagimet Biosciences Inc. | 2 Million USD | -15245.55% |
| MediciNova, Inc. | 1 Million USD | -30591.1% |
| Praxis Precision Medicines, Inc. | 2.44 Million USD | -12442.338% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -1798382.274% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 270.6 Million USD | -13.419% |
| Biomea Fusion, Inc. | - USD | -Infinity% |
| PTC Therapeutics, Inc. | 937.82 Million USD | 67.274% |
| Mereo BioPharma Group plc | 10 Million USD | -2969.11% |
| Cullinan Oncology, Inc. | - USD | -Infinity% |
| Syndax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Absci Corporation | 5.71 Million USD | -5267.454% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 20.72 Million USD | -1381.016% |
| Dyne Therapeutics, Inc. | - USD | -Infinity% |
| Kiniksa Pharmaceuticals, Ltd. | 270.25 Million USD | -13.562% |
| Ventyx Biosciences, Inc. | - USD | -Infinity% |
| Allakos Inc. | - USD | -Infinity% |
| Imunon, Inc. | - USD | -Infinity% |
| Fulcrum Therapeutics, Inc. | 2.8 Million USD | -10841.569% |
| Corcept Therapeutics Incorporated | 482.37 Million USD | 36.375% |
| BioAtla, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | - USD | -Infinity% |
| Allogene Therapeutics, Inc. | 95 Thousand USD | -322964.211% |
| Larimar Therapeutics, Inc. | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -6350.42% |
| Kezar Life Sciences, Inc. | 7 Million USD | -4284.443% |
| Cara Therapeutics, Inc. | 20.96 Million USD | -1363.711% |
| aTyr Pharma, Inc. | 353 Thousand USD | -86843.626% |
| Aligos Therapeutics, Inc. | 15.52 Million USD | -1876.373% |
| Akero Therapeutics, Inc. | - USD | -Infinity% |
| Viridian Therapeutics, Inc. | 314 Thousand USD | -97642.357% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 12.05 Thousand USD | -2544978.365% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 829.25 Million USD | 62.989% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -135576.457% |
| UroGen Pharma Ltd. | 82.71 Million USD | -271.055% |
| Sutro Biopharma, Inc. | 153.73 Million USD | -99.642% |
| ZIVO Bioscience, Inc. | 27.65 Thousand USD | -1109885.533% |
| Orgenesis Inc. | 530 Thousand USD | -57807.736% |
| Entera Bio Ltd. | - USD | -Infinity% |
| GH Research PLC | - USD | -Infinity% |
| Lisata Therapeutics, Inc. | - USD | -Infinity% |
| Reneo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 168.33 Million USD | -82.318% |
| 60 Degrees Pharmaceuticals, Inc. | 253.57 Thousand USD | -120934.574% |
| Replimune Group, Inc. | - USD | -Infinity% |
| Coeptis Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Vanda Pharmaceuticals Inc. | 192.64 Million USD | -59.318% |
| Lexaria Bioscience Corp. | 226.2 Thousand USD | -135576.457% |
| Portage Biotech Inc. | - USD | -Infinity% |
| Cardio Diagnostics Holdings, Inc. | 17.06 Thousand USD | -1798382.274% |
| Olema Pharmaceuticals, Inc. | - USD | -Infinity% |
| OncoCyte Corporation | 1.5 Million USD | -20319.894% |
| Qualigen Therapeutics, Inc. | 5.2 Million USD | -5796.742% |
| Processa Pharmaceuticals, Inc. | - USD | -Infinity% |
| Purple Biotech Ltd. | - USD | -Infinity% |
| CollPlant Biotechnologies Ltd. | 10.95 Million USD | -2700.538% |
| scPharmaceuticals Inc. | 13.59 Million USD | -2157.861% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | - USD | -Infinity% |
| NeuroSense Therapeutics Ltd. | - USD | -Infinity% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | - USD | -Infinity% |
| Curis, Inc. | 10.02 Million USD | -2962.067% |
| Daré Bioscience, Inc. | 2.8 Million USD | -10830.327% |
| Carmell Therapeutics Corporation | - USD | -Infinity% |
| Titan Pharmaceuticals, Inc. | 184 Thousand USD | -166699.457% |
| Achieve Life Sciences, Inc. | - USD | -Infinity% |
| BeiGene, Ltd. | 2.45 Billion USD | 87.518% |
| Kiromic BioPharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. Warrant | 11.58 Million USD | -2550.354% |
| Protagonist Therapeutics, Inc. | 60 Million USD | -411.518% |
| Erasca, Inc. | - USD | -Infinity% |
| bluebird bio, Inc. | 29.49 Million USD | -940.482% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 2.41 Billion USD | 87.314% |
| DBV Technologies S.A. | 15.72 Million USD | -1851.367% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | 6.84 Billion USD | 95.518% |
| Vincerx Pharma, Inc. | - USD | -Infinity% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -3733.512% |
| Molecular Templates, Inc. | 57.3 Million USD | -435.565% |
| Acrivon Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Travere Therapeutics, Inc. | 145.23 Million USD | -111.316% |
| Monte Rosa Therapeutics, Inc. | - USD | -Infinity% |
| Spruce Biosciences, Inc. | 10.08 Million USD | -2942.036% |
| Celldex Therapeutics, Inc. | 6.88 Million USD | -4358.971% |
| Cogent Biosciences, Inc. | - USD | -Infinity% |
| MacroGenics, Inc. | 58.74 Million USD | -422.411% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | - USD | -Infinity% |
| Aditxt, Inc. | 645.17 Thousand USD | -47470.12% |
| Adagene Inc. | 18.11 Million USD | -1594.565% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -28265.157% |
| Maravai LifeSciences Holdings, Inc. | 288.94 Million USD | -6.218% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 250 Million USD | -22.76% |
| SciSparc Ltd. | 2.87 Million USD | -10560.333% |
| Vericel Corporation | 197.51 Million USD | -55.385% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 5.9 Million USD | -5098.357% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 59.6 Million USD | -414.9% |
| Invivyd, Inc. | - USD | -Infinity% |
| Relay Therapeutics, Inc. | 25.54 Million USD | -1101.405% |
| Quoin Pharmaceuticals, Ltd. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 96.73 Million USD | -217.27% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 100.38 Million USD | -205.728% |
| ADMA Biologics, Inc. | 258.21 Million USD | -18.859% |
| Clene Inc. | 654 Thousand USD | -46828.287% |
| Capricor Therapeutics, Inc. | 25.17 Million USD | -1118.962% |
| Boundless Bio, Inc. Common Stock | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 44.57 Million USD | -588.527% |
| Citius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Contineum Therapeutics, Inc. Class A Common Stock | 50 Million USD | -513.822% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 107 Thousand USD | -286732.71% |
| ALX Oncology Holdings Inc. | - USD | -Infinity% |
| Vir Biotechnology, Inc. | 86.18 Million USD | -256.128% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -419681.978% |
| Ocular Therapeutix, Inc. | 58.44 Million USD | -425.146% |
| Verve Therapeutics, Inc. | 11.75 Million USD | -2510.231% |
| Trevena, Inc. | 3.12 Million USD | -9721.152% |
| Surrozen, Inc. | - USD | -Infinity% |
| Tyra Biosciences, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 726.43 Million USD | 57.751% |
| Connect Biopharma Holdings Limited | - USD | -Infinity% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 6.28 Million USD | -4780.9% |
| Bolt Biotherapeutics, Inc. | 7.87 Million USD | -3796.788% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | - USD | -Infinity% |
| Statera Biopharma, Inc. | - USD | -Infinity% |
| ImmunityBio, Inc. | 622 Thousand USD | -49242.605% |
| Korro Bio, Inc. | - USD | -Infinity% |
| Kineta, Inc. | 5.44 Million USD | -5539.673% |
| BioVie Inc. | - USD | -Infinity% |
| Codexis, Inc. | 70.14 Million USD | -337.55% |
| Celularity Inc. | 22.77 Million USD | -1247.815% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -7547.919% |
| Celcuity Inc. | - USD | -Infinity% |
| Virax Biolabs Group Limited | 156.41 Thousand USD | -196110.818% |
| Cibus, Inc. | 1.81 Million USD | -16791.084% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | - USD | -Infinity% |
| Annexon, Inc. | - USD | -Infinity% |
| Adverum Biotechnologies, Inc. | 3.6 Million USD | -8425.306% |
| Assembly Biosciences, Inc. | 7.16 Million USD | -4184.671% |
| Avalo Therapeutics, Inc. | 1.92 Million USD | -15851.715% |
| Ionis Pharmaceuticals, Inc. | 787.64 Million USD | 61.034% |
| Eyenovia, Inc. | 3787.00 USD | -8104230.605% |
| Puma Biotechnology, Inc. | 235.63 Million USD | -30.247% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | - USD | -Infinity% |
| Arcellx, Inc. | 110.31 Million USD | -178.203% |
| Cardiff Oncology, Inc. | 488 Thousand USD | -62791.598% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -287.494% |
| Regulus Therapeutics Inc. | - USD | -Infinity% |
| Moolec Science SA | 905.04 Thousand USD | -33810.982% |
| Acumen Pharmaceuticals, Inc. | - USD | -Infinity% |
| Geron Corporation | 237 Thousand USD | -129398.312% |
| LAVA Therapeutics N.V. | 6.76 Million USD | -4434.067% |
| Royalty Pharma plc | 2.35 Billion USD | 86.965% |
| Atea Pharmaceuticals, Inc. | - USD | -Infinity% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 733.87 Thousand USD | -41720.838% |
| Mersana Therapeutics, Inc. | 36.85 Million USD | -732.753% |
| Humacyte, Inc. | - USD | -Infinity% |
| Structure Therapeutics Inc. | - USD | -Infinity% |
| 89bio, Inc. | - USD | -Infinity% |
| PMV Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 170 Thousand USD | -180435.882% |
| Trevi Therapeutics, Inc. | - USD | -Infinity% |
| Lexicon Pharmaceuticals, Inc. | 1.2 Million USD | -25390.947% |
| Notable Labs, Ltd. | 310 Thousand USD | -98903.548% |
| Liquidia Corporation | 17.48 Million USD | -1654.981% |
| Mustang Bio, Inc. | - USD | -Infinity% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 1.08 Million USD | -28265.157% |
| Arbutus Biopharma Corporation | 18.14 Million USD | -1591.809% |
| DiaMedica Therapeutics Inc. | - USD | -Infinity% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -16382.868% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 1.71 Million USD | -17820.816% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | - USD | -Infinity% |
| PepGen Inc. | - USD | -Infinity% |
| Moleculin Biotech, Inc. | - USD | -Infinity% |
| United Therapeutics Corporation | 2.32 Billion USD | 86.814% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 72.1 Thousand USD | -425562.256% |
| Belite Bio, Inc | - USD | -Infinity% |
| XOMA Corporation | 4.75 Million USD | -6350.42% |
| ARS Pharmaceuticals, Inc. | 30 Thousand USD | -1022936.667% |
| Bionomics Limited | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| uniQure N.V. | 15.84 Million USD | -1837.203% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 64.7 Million USD | -374.338% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | - USD | -Infinity% |
| Altimmune, Inc. | 426 Thousand USD | -71944.836% |
| Amicus Therapeutics, Inc. | 399.35 Million USD | 23.149% |
| Alpha Tau Medical Ltd. | - USD | -Infinity% |
| Compugen Ltd. | 33.45 Million USD | -817.275% |
| Peak Bio, Inc. | 367.87 Thousand USD | -83327.613% |
| Zevra Therapeutics, Inc. | 27.46 Million USD | -1017.625% |
| Benitec Biopharma Inc. | 216 Thousand USD | -141988.426% |
| Spyre Therapeutics, Inc. | 886 Thousand USD | -34540.068% |
| NKGen Biotech, Inc. Common Stock | - USD | -Infinity% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | - USD | -Infinity% |
| Aileron Therapeutics, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | - USD | -Infinity% |
| Instil Bio, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | 74.973% |
| Immunome, Inc. | 14.01 Million USD | -2089.406% |
| Compass Therapeutics, Inc. | - USD | -Infinity% |
| Verona Pharma plc | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | - USD | -Infinity% |
| Shattuck Labs, Inc. | 1.65 Million USD | -18422.088% |
| CervoMed Inc. | 7.14 Million USD | -4195.542% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 4.91 Million USD | -6146.916% |
| Dianthus Therapeutics, Inc. | 2.82 Million USD | -10760.262% |
| Moolec Science SA | 905.04 Thousand USD | -33810.982% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 832.01 Thousand USD | -36787.898% |
| AnaptysBio, Inc. | 17.15 Million USD | -1688.838% |
| Design Therapeutics, Inc. | - USD | -Infinity% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 2.46 Million USD | -12375.808% |
| Seelos Therapeutics, Inc. | 2.2 Million USD | -13831.502% |
| Lumos Pharma, Inc. | 2.05 Million USD | -14863.969% |
| Achilles Therapeutics plc | - USD | -Infinity% |
| enGene Holdings Inc. Common Stock | - USD | -Infinity% |
| 180 Life Sciences Corp. | - USD | -Infinity% |
| Opiant Pharmaceuticals, Inc. | 40.72 Million USD | -653.615% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 2.08 Million USD | -14617.736% |
| ORIC Pharmaceuticals, Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | 204 Thousand USD | -150346.569% |
| Fractyl Health, Inc. Common Stock | 120 Thousand USD | -255659.167% |
| Rani Therapeutics Holdings, Inc. | - USD | -Infinity% |
| MoonLake Immunotherapeutics | - USD | -Infinity% |
| Palisade Bio, Inc. | 250 Thousand USD | -122664.4% |
| Tourmaline Bio, Inc. | - USD | -Infinity% |
| Beam Therapeutics Inc. | 377.7 Million USD | 18.744% |
| Neurogene Inc. | - USD | -Infinity% |
| Mirum Pharmaceuticals, Inc. | 186.37 Million USD | -64.675% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Sesen Bio, Inc. | 40 Million USD | -667.278% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1.18 Million USD | -25712.532% |
| Taysha Gene Therapies, Inc. | 15.45 Million USD | -1886.35% |
| Athira Pharma, Inc. | - USD | -Infinity% |
| Vaccinex, Inc. | 570 Thousand USD | -53744.035% |
| HCW Biologics Inc. | 2.84 Million USD | -10699.903% |
| XOMA Corporation | 4.75 Million USD | -6350.42% |
| Nektar Therapeutics | 90.12 Million USD | -240.551% |
| Arvinas, Inc. | 78.5 Million USD | -290.969% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | 43.94 Million USD | -598.366% |
| Omega Therapeutics, Inc. | 3.09 Million USD | -9819.554% |
| Quince Therapeutics, Inc. | - USD | -Infinity% |
| Rezolute, Inc. | - USD | -Infinity% |
| Clene Inc. | 654 Thousand USD | -46828.287% |
| Indaptus Therapeutics, Inc. | - USD | -Infinity% |
| BeyondSpring Inc. | 1.75 Million USD | -17427.756% |
| Synlogic, Inc. | 3.37 Million USD | -9004.45% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | 367.87 Thousand USD | -83327.613% |
| Werewolf Therapeutics, Inc. | 19.94 Million USD | -1438.941% |
| Krystal Biotech, Inc. | 50.69 Million USD | -505.359% |
| Karyopharm Therapeutics Inc. | 146.03 Million USD | -110.166% |
| SpringWorks Therapeutics, Inc. | 5.44 Million USD | -5534.496% |
| Lipella Pharmaceuticals Inc. | 449.61 Thousand USD | -68160.542% |
| MannKind Corporation | 198.96 Million USD | -54.256% |
| Ikena Oncology, Inc. | 9.16 Million USD | -3250.557% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 113.45 Million USD | -170.525% |
| Gossamer Bio, Inc. | - USD | -Infinity% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | - USD | -Infinity% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 285.14 Million USD | -7.634% |
| Mural Oncology plc | - USD | -Infinity% |
| Biora Therapeutics, Inc. | 4000.00 USD | -7672675.0% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | - USD | -Infinity% |
| Champions Oncology, Inc. | 50.15 Million USD | -511.925% |
| REGENXBIO Inc. | 90.24 Million USD | -240.098% |
| Ensysce Biosciences, Inc. | 2.23 Million USD | -13659.617% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | - USD | -Infinity% |
| Edgewise Therapeutics, Inc. | - USD | -Infinity% |
| Vaxart, Inc. | 7.37 Million USD | -4059.249% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | - USD | -Infinity% |
| Cellectis S.A. | 755 Thousand USD | -40550.464% |
| Longeveron Inc. | 709 Thousand USD | -43187.87% |
| Repare Therapeutics Inc. | 51.13 Million USD | -500.221% |
| Sarepta Therapeutics, Inc. | 1.24 Billion USD | 75.316% |
| Inozyme Pharma, Inc. | - USD | -Infinity% |
| Revolution Medicines, Inc. | 11.58 Million USD | -2550.354% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | - USD | -Infinity% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 210 Thousand USD | -146048.095% |
| Vertex Pharmaceuticals Incorporated | 9.86 Billion USD | 96.89% |
| Denali Therapeutics Inc. | 330.53 Million USD | 7.146% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 16.29 Million USD | -1783.241% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | - USD | -Infinity% |
| Passage Bio, Inc. | - USD | -Infinity% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | - USD | -Infinity% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -11254.458% |
| Scinai Immunotherapeutics Ltd. | - USD | -Infinity% |
| Rhythm Pharmaceuticals, Inc. | 77.42 Million USD | -296.382% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 152.43 Thousand USD | -201245.536% |
| Carisma Therapeutics, Inc. | 14.91 Million USD | -1957.182% |
| Unicycive Therapeutics, Inc. | 675 Thousand USD | -45368.296% |
| OmniAb, Inc. | 34.16 Million USD | -798.346% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 21.25 Million USD | -1344.151% |
| Lipocine Inc. | -2.85 Million USD | 10865.717% |
| Lexeo Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Nautilus Biotechnology, Inc. | - USD | -Infinity% |
| SAB Biotherapeutics, Inc. | 2.23 Million USD | -13607.558% |
| G1 Therapeutics, Inc. | 82.51 Million USD | -271.964% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | 86.45 Million USD | -254.995% |
| Ocugen, Inc. | 6.03 Million USD | -4984.675% |
| Mind Medicine (MindMed) Inc. | - USD | -Infinity% |
| Q32 Bio Inc. | 1.15 Million USD | -26449.394% |
| Brainstorm Cell Therapeutics Inc. | - USD | -Infinity% |
| Alumis Inc. Common Stock | - USD | -Infinity% |
| Equillium, Inc. | 36.08 Million USD | -750.546% |
| Kyverna Therapeutics, Inc. | - USD | -Infinity% |
| Coya Therapeutics, Inc. | 6 Million USD | -5013.303% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | - USD | -Infinity% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 633.1 Thousand USD | -48377.339% |
| Dominari Holdings Inc. | 2.03 Million USD | -14952.035% |
| Edesa Biotech, Inc. | - USD | -Infinity% |
| vTv Therapeutics Inc. | - USD | -Infinity% |
| Bio-Techne Corporation | 1.15 Billion USD | 73.521% |
| Agios Pharmaceuticals, Inc. | 26.82 Million USD | -1044.208% |
| Harmony Biosciences Holdings, Inc. | 582.02 Million USD | 47.268% |
| Prelude Therapeutics Incorporated | - USD | -Infinity% |
| Candel Therapeutics, Inc. | - USD | -Infinity% |
| iTeos Therapeutics, Inc. | 12.59 Million USD | -2336.769% |
| Nkarta, Inc. | - USD | -Infinity% |
| BioCardia, Inc. | 477 Thousand USD | -64241.929% |
| Iterum Therapeutics plc | - USD | -Infinity% |